MedTrace Logo

Study to Evaluate Effects of Investigational Drug on Oxygenation in Healthy Volunteers Under Hypoxic Conditions

NCT03051711 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2019-10-04

No results posted yet for this study

Summary

To evaluate the effect of GBT440 on oxygen saturation at rest and exercise, under hypoxic conditions, at Day 15 compared to Baseline.

Conditions

  • Cardio-pulmonary Function

Interventions

DRUG

GBT440

Capsules which contain GBT440 drug substance in Swedish Orange

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER

  • Global Blood Therapeutics

    lead INDUSTRY

Principal Investigators

  • Ganesh Balaratnam, MBChB, BAO · Global Blood Therapeutics

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-12-01
Completion
2018-02-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03051711 on ClinicalTrials.gov